                         SEQUENCE LISTING

<110>  Consiglio Nazionale delle Ricerche
 
<120>  A fusion protein, a nanoparticle composed of a plurality of 
       monomers of said fusion protein  and uses thereof

<130>  I0160220-EC

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  183
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Thr Thr Ala Ser Thr Ser Gln Val Arg Gln Asn Tyr His Gln Asp 
1               5                   10                  15      


Ser Glu Ala Ala Ile Asn Arg Gln Ile Asn Leu Glu Leu Tyr Ala Ser 
            20                  25                  30          


Tyr Val Tyr Leu Ser Met Ser Tyr Tyr Phe Asp Arg Asp Asp Val Ala 
        35                  40                  45              


Leu Lys Asn Phe Ala Lys Tyr Phe Leu His Gln Ser His Glu Glu Arg 
    50                  55                  60                  


Glu His Ala Glu Lys Leu Met Lys Leu Gln Asn Gln Arg Gly Gly Arg 
65                  70                  75                  80  


Ile Phe Leu Gln Asp Ile Lys Lys Pro Asp Cys Asp Asp Trp Glu Ser 
                85                  90                  95      


Gly Leu Asn Ala Met Glu Cys Ala Leu His Leu Glu Lys Asn Val Asn 
            100                 105                 110         


Gln Ser Leu Leu Glu Leu His Lys Leu Ala Thr Asp Lys Asn Asp Pro 
        115                 120                 125             


His Leu Cys Asp Phe Ile Glu Thr His Tyr Leu Asn Glu Gln Val Lys 
    130                 135                 140                 


Ala Ile Lys Glu Leu Gly Asp His Val Thr Asn Leu Arg Lys Met Gly 
145                 150                 155                 160 


Ala Pro Glu Ser Gly Leu Ala Glu Tyr Leu Phe Asp Lys His Thr Leu 
                165                 170                 175     


Gly Asp Ser Asp Asn Glu Ser 
            180             


<210>  2
<211>  183
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Heavy chain human ferritin variant (vHFt)

<400>  2

Met Thr Thr Ala Ser Thr Ser Gln Val Arg Gln Asn Tyr His Gln Asp 
1               5                   10                  15      


Ser Glu Ala Ala Ile Asn Arg Gln Ile Asn Leu Glu Leu Tyr Ala Ser 
            20                  25                  30          


Tyr Val Tyr Leu Ser Met Ser Tyr Tyr Phe Asp Arg Asp Asp Val Ala 
        35                  40                  45              


Leu Lys Asn Phe Ala Lys Tyr Phe Leu His Gln Ser His Glu Lys Arg 
    50                  55                  60                  


Glu Gly Ala Glu Lys Leu Met Lys Leu Gln Asn Gln Arg Gly Gly Arg 
65                  70                  75                  80  


Ile Phe Leu Gln Asp Ile Lys Lys Pro Asp Cys Asp Asp Trp Glu Ser 
                85                  90                  95      


Gly Leu Asn Ala Met Glu Cys Ala Leu His Leu Glu Lys Asn Val Asn 
            100                 105                 110         


Gln Ser Leu Leu Glu Leu His Lys Leu Ala Thr Asp Lys Asn Asp Pro 
        115                 120                 125             


His Leu Cys Asp Phe Ile Glu Thr His Tyr Leu Asn Glu Gln Val Lys 
    130                 135                 140                 


Ala Ile Lys Glu Leu Gly Asp His Val Thr Asn Leu Arg Lys Met Gly 
145                 150                 155                 160 


Ala Pro Glu Ser Gly Leu Ala Glu Tyr Leu Phe Asp Lys His Thr Leu 
                165                 170                 175     


Gly Asp Ser Asp Asn Glu Ser 
            180             


<210>  3
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide mimicking a MMP cleavage site

<400>  3

Gly Pro Leu Gly Ile Ala Gly Gln 
1               5               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide mimicking a MMP cleavage site

<400>  4

Gly Pro Gln Gly Ile Trp Gly Gln 
1               5               


<210>  5
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide mimicking a MMP cleavage site

<400>  5

Pro Leu Gly Leu Ala Gly 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide mimicking a MMP cleavage site

<400>  6

Pro Val Gly Leu Ile Gly 
1               5       


<210>  7
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide mimicking a MMP cleavage site

<400>  7

Cys Gly Leu Asp Asp 
1               5   


<210>  8
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide with repeated MMP cleavage sites

<400>  8

Gly Pro Leu Gly Ile Ala Gly Gln Gly Pro Leu Gly Ile Ala Gly Gln 
1               5                   10                  15      


<210>  9
<211>  40
<212>  PRT
<213>  artificial sequence

<220>
<223>  PAS sequence

<400>  9

Ala Ser Pro Ala Ala Pro Ala Pro Ala Ser Pro Ala Ala Pro Ala Pro 
1               5                   10                  15      


Ser Ala Pro Ala Ala Ser Pro Ala Ala Pro Ala Pro Ala Ser Pro Ala 
            20                  25                  30          


Ala Pro Ala Pro Ser Ala Pro Ala 
        35                  40  


<210>  10
<211>  75
<212>  PRT
<213>  artificial sequence

<220>
<223>  PAS sequence

<400>  10

Ala Ser Pro Ala Ala Pro Ala Pro Ala Ser Pro Ala Ala Pro Ala Pro 
1               5                   10                  15      


Ser Ala Pro Ala Ala Ser Pro Ala Ala Pro Ala Pro Ala Ser Pro Ala 
            20                  25                  30          


Ala Pro Ala Pro Ser Ala Pro Ala Ala Ser Pro Ala Ala Pro Ala Pro 
        35                  40                  45              


Ala Ser Pro Ala Ala Pro Ala Pro Ser Ala Pro Ala Ala Ser Pro Ala 
    50                  55                  60                  


Ala Pro Ala Pro Ala Ser Pro Ala Ala Pro Ala 
65                  70                  75  


